بدائل البحث:
greater decrease » greatest decrease (توسيع البحث), greater increase (توسيع البحث), greater disease (توسيع البحث)
we decrease » nn decrease (توسيع البحث), mean decrease (توسيع البحث), teer decrease (توسيع البحث)
a decrease » _ decreased (توسيع البحث), _ decreases (توسيع البحث), mean decrease (توسيع البحث)
_ decrease » _ decreased (توسيع البحث), _ decreasing (توسيع البحث)
يعرض 1 - 20 نتائج من 128 نتيجة بحث عن '(( predefined ((we decrease) OR (((a decrease) OR (_ decrease)))) ) OR ( fold greater decrease ))', وقت الاستعلام: 0.38s تنقيح النتائج
  1. 1
    Negative ion mode significant differential metabolites (Fold Change greater than 2 or less than 0.5).

    Negative ion mode significant differential metabolites (Fold Change greater than 2 or less than 0.5). حسب Peng-fei Han (694841)

    منشور في 2025
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Positive ion mode significant differential metabolites (Fold Change greater than 2 or less than 0.5).

    Positive ion mode significant differential metabolites (Fold Change greater than 2 or less than 0.5). حسب Peng-fei Han (694841)

    منشور في 2025
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Gating strategy of experiment using 30 min EdU pulses experiments in mOr2-Piwi1 juvenile polyps.

    Gating strategy of experiment using 30 min EdU pulses experiments in mOr2-Piwi1 juvenile polyps. حسب Eudald Pascual-Carreras (12115380)

    منشور في 2025
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Changes in the physiological indexes of two oat varieties under drought stress and normal water supply treatments.

    Changes in the physiological indexes of two oat varieties under drought stress and normal water supply treatments. حسب Caijin Chen (3107787)

    منشور في 2025
    الموضوعات:
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    WGCNA of the sample characteristics and proteins of the two oat varieties under drought stress.

    WGCNA of the sample characteristics and proteins of the two oat varieties under drought stress. حسب Caijin Chen (3107787)

    منشور في 2025
    الموضوعات:
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Changes in the growth of two oat varieties under drought stress and normal water supply treatments.

    Changes in the growth of two oat varieties under drought stress and normal water supply treatments. حسب Caijin Chen (3107787)

    منشور في 2025
    الموضوعات:
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Volcano map of DAPs.

    Volcano map of DAPs. حسب Caijin Chen (3107787)

    منشور في 2025
    الموضوعات:
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    KEGG pathway enrichment bubble map of the top 20 DAPs.

    KEGG pathway enrichment bubble map of the top 20 DAPs. حسب Caijin Chen (3107787)

    منشور في 2025
    الموضوعات:
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Normalized sample plots for each treatment for data quality control.

    Normalized sample plots for each treatment for data quality control. حسب Caijin Chen (3107787)

    منشور في 2025
    الموضوعات:
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Basic physical and chemical properties of the soils.

    Basic physical and chemical properties of the soils. حسب Caijin Chen (3107787)

    منشور في 2025
    الموضوعات:
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Different responses of two oat varieties to drought stress.

    Different responses of two oat varieties to drought stress. حسب Caijin Chen (3107787)

    منشور في 2025
    الموضوعات:
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    GO enrichment of DAPs, including BP, CC, and MF.

    GO enrichment of DAPs, including BP, CC, and MF. حسب Caijin Chen (3107787)

    منشور في 2025
    الموضوعات:
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    Characterization of miRNA expression profiles and their potential targets upon Bz and Bz + PTX therapy in chronically infected mice. Relative expression was expressed as fold change (2<sup>-ΔΔCt</sup>). miRNAs with a fold change greater than 1.3 in the vehicle group and at the 0.75–1.3 range (orange striped area) in the Bz and Bz + PTX therapy groups were considered to have a restored expression. They were selected for further analysis on IPA software. (A) The expression of miRNAs was altered in the infected group and an expression was restored after Bz therapy. (B) Top canonical activated pathways in the infected group with a restored expression upon Bz therapy. (C) Diseases and disorders pathway analysis. (D) The expression of miRNAs was altered in the infected group and restored upon Bz + PTX therapy. (E) Top canonical activated pathways in the infected group with a restored expression upon Bz therapy. (F) Diseases and disorders pathway analysis. Significant intervals

    Characterization of miRNA expression profiles and their potential targets upon Bz and Bz + PTX therapy in chronically infected mice. Relative expression was expressed as fold chang... حسب Glaucia Vilar-Pereira (686134)

    منشور في 2025
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Global transcriptional analysis for activated gametocytes of Δ<i>pbpp6</i> parasites by RNA-seq.

    Global transcriptional analysis for activated gametocytes of Δ<i>pbpp6</i> parasites by RNA-seq. حسب Yonghui Feng (12227596)

    منشور في 2025
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    Difference in patients’ outcomes between years 2022 and 2023.

    Difference in patients’ outcomes between years 2022 and 2023. حسب Rawan T. Tafish (21736177)

    منشور في 2025
    الموضوعات:
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    Meropenem Consumption Across Quarters of 2022-2023: Defined Daily Dose (Blue Bars) and Antimicrobial Cost per Patient Day (Red Line).

    Meropenem Consumption Across Quarters of 2022-2023: Defined Daily Dose (Blue Bars) and Antimicrobial Cost per Patient Day (Red Line). حسب Rawan T. Tafish (21736177)

    منشور في 2025
    الموضوعات:
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    Estimated Cost Savings and Expenditures During the Gradual Implementation of an AMS Program Across Quarters in 2022–2023.

    Estimated Cost Savings and Expenditures During the Gradual Implementation of an AMS Program Across Quarters in 2022–2023. حسب Rawan T. Tafish (21736177)

    منشور في 2025
    الموضوعات:
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    Pattern of meropenem prescription expressed as DDD per 1000 across medical specialties: 2022-2023.

    Pattern of meropenem prescription expressed as DDD per 1000 across medical specialties: 2022-2023. حسب Rawan T. Tafish (21736177)

    منشور في 2025
    الموضوعات:
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    Quarterly Trends in DDD per 1000 Patient-Days and Statistical Comparisons for 2022–2023.

    Quarterly Trends in DDD per 1000 Patient-Days and Statistical Comparisons for 2022–2023. حسب Rawan T. Tafish (21736177)

    منشور في 2025
    الموضوعات:
    أضف إلى المفضلة
    محفوظ في:
  20. 20
    Descriptive Data of Meropenem Compliance Indicators, 2022–2023.

    Descriptive Data of Meropenem Compliance Indicators, 2022–2023. حسب Rawan T. Tafish (21736177)

    منشور في 2025
    الموضوعات:
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: